lnkd.in/g6vFMK8

Approximately 180,000 patients can be considered potential #TAVI candidates in the EU and US annually and this number might increase up to 270,000 if indications for TAVI expand to low-risk patients bit.ly/2LgDxiO European Society of Cardiology #ESCCoT #TAVR #freeaccess #epidemiology

Al mijn kinderen zijn gevaccineerd. Extra vaccinaties voor onze reis door Indonesië. Mijn schoonvader, #huisarts wijlen Adriaan Mazel promoveerde op #hepatitis B vaccinaties bij zwangeren. Er is overweldigende evidence dat vaccinaties werken dus #ikvaccineer #antivax = #amathia

Alright here's another q. I'll be asking... What are the implications of healthy, young people getting monitored with a heart rate sensor and ECG by a consumer device? As far as I can tell, this will be the first time it's been studied (this isn't considered a high risk group).

Will there be any cardiologists or radiologists left when tech companies are done hiring? Kidding. Kinda...

How do I quickly and efficiently analyse new and important trials 📊? Join us for a crash Course in Clinical Research at #EuroPCR! Dejan Milasinovic tells us more! ow.ly/Awx530ozoj8 #interventionalcardiology

Clinical Research – Confused by meta-analysis? Ruben Osnabrugge tells you why you should attend these #EuroPCR sessions to learn about the essentials needed for understanding the structure and the significance of meta-analysis View programme ow.ly/PCbV30oDjbg

New this year at #EuroPCR on May 23! PCR Clinical Research Module 3 - Be part of the team that creates the evidence – join marie claude morice, Beatriz and Goran Stankovic, MD, PhD for the LIVE demonstration of left main PCI in the EBC MAIN trial from Massy, France youtube.com/watch?v=gaUhiq…

Back to the drawing board (literally), with Ruben Osnabrugge and Chris Cook at PCR Clinical Research - How to interpret a meta-analysis

To recap: a LM patient who accepted to participate to the #EBCMAIN trial was randomized to provisional stenting, perfectly treated live by the team (with 1 bailout stent) and we in the audience got tips from both the clinical and research viewpoints. Mission accomplished, team.

#EuroPCR 2019 is now at an end, but the story continues! Merci to those who joined us in person for this wonderful week in Paris & to the #interventionalcardiology family who followed via #cardiotwitter. Safe travels & rendez-vous next year for #EuroPCR 2020 👍🏼

My origins at ICPS with my mentor. This PCR made me connect....what I was with What I am and with a new future. Proud!!! marie claude morice, Antonio Serra , @nico_piazza, neus salvatella, Jose Ramon Rumoroso, Cesar Moris, Felipe Hernández, Davide Capodanno, Dejan Milasinovic, Chris Cook,Ruben Osnabrugge, Goran Stankovic, MD, PhD

Gooi open die peer review nrc.nl/nieuws/2019/10…

Exciting times... one of the biggest and longest coronary artery disease trials ever to be unveiled soon... stay tuned ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain tctmd.com/news/ischemia-…

@eacts #ICVTS Statistical Primer by myself and colleagues: "Statistical primer: performing repeated-measures analysis": bit.ly/2orUgl2 Domenico Pagano Attila Kappetein Ruben Osnabrugge

Interesting talk by @nicky56 on #IBMWatson at the NVEC, future of medicine

NVEC discussie over robotchirurgie: evidence en value based? lnkd.in/ga78VaJ

Interesting forecast by Ruben Osnabrugge and Attila Kappetein on the future #TAVI #TAVR requirements in the future. academic.oup.com/eurheartj/adva…

lnkd.in/gMytMDV

Game over voor Yates.